European stocks look like newly good investments amid Trump's tariff war and US economic unpredictabilities. European defense stocks are particularly appealing.

Supply Lines is a daily newsletter that tracks global trade. Sign up here.Most Read from BloombergTrump DEI Purge Hits ...

The global market for acute migraine treatment is on a steady growth trajectory, with sales expected to rise from USD 2,700.7 million in 2024 to USD 4,194.1 million by 2034, reflecting a CAGR of 4.5% ...

It was perhaps not the welcome Irish Prime Minister Micheal Martin had hoped for on an annual US trip to mark Saint Patrick's ...

Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...

The two companies will work together on Zealand’s amylin analogue petrelintide as a monotherapy and in combination therapies.

The "Liraglutide and Semaglutide Market by Type, by Route of Administration, by Application, by Distribution Channel, and by Region" report has been added to ResearchAndMarkets.com's offering. The ...

Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...

The latest research report published by Vantage Market Research, titled "An Increase in Demand and Opportunities for the ...

Thirty-six weeks of once-daily, oral baricitinib was associated with greater hair regrowth on the scalp, eyebrows and ...